Cartography secures $67M in pursuit of ‘differentiated’ cancer drugs

The company is working on T cell engagers and other multifunctional antibodies, led by a prospect it believes might be ...
The Pharma Letter

Cartography closes $67 million Series B

California-based Cartography Biosciences, an oncology company advancing a pipeline of T-cell engaging bispecific and ...
Precision Medicine Online

Cartography Biosciences Raises $67M in Series B Financing

The firm will use the funding to launch its T-cell engager candidate into clinical trials early next year in LY6G6D-expressing colorectal cancer.
The Bakersfield Californian

Cartography Secures $67 Million Series B Financing to Advance Differentiated Oncology Pipeline of Antibody-Based Therapies into the Clinic

Cartography Biosciences, Inc., an oncology company advancing an innovative pipeline of T-cell engaging bispecific and multi-specific antibody therapeutics that target novel and highly specific tumor ...
Business Wire

Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts

SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Cartography Biosciences, an immuno-oncology company creating biologic therapies against novel targets guided by the first-ever comprehensive antigen atlas, today ...
Business Wire

Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cartography Biosciences, Inc., an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the ...
CU Boulder News & Events

This is not a Pipe but a Special Issue on the Scholarship and Impacts of Professor Emerita Barbara P. Buttenfield on Cartography and GIScience

A special issue appeared in the Cartography and Geographic Information Science journal (volume 51, number 5) was put together to recognize Prof. Barbara P. Buttenfield's (Babs') 35+ years of ...